Please login to the form below

Not currently logged in
Email:
Password:

Lannett appoints Teva’s Michael Bogda as president

He served as VP of technical operations in for Teva’s Americas division

Generic pharmaceuticals company Lannett has named Michael Bogda as its new president.

Bogda joins from Israeli firm Teva, where he served as VP for its technical operations in the Americas region.

Prior to this, Bogda held a number of roles at Barr Pharma, working his way up to the position of president and chief operating officer of Barr Laboratories. Previously, Bogda served as VP of operations for Copley Pharma.

Commenting on his new role, Bogda said: “The company has made great progress in building a vertically integrated pain management business, formed strategic alliances and developed a deep pipeline focused on controlled substances.

“I am enthusiastic and energised about the opportunities ahead and look forward to working to continue to execute Lannett's strategic priorities.”

Former president Arthur Bedrosian will remain in at the company in his current CEO role.

Bedrosian said: “To address our rapid growth, as well as our long-term succession planning efforts, we embarked upon a search for a high quality individual and we found one.

“Michael brings a global perspective, in addition to extensive operations, merger and acquisitions and business integration experience. We welcome Michael and look forward to his insight as we look to take our company to its next stage of growth and development.”

22nd December 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics